PHARMACEUTICAL COMPOSITION EFFECTIVE IN PREVENTING THE ADVERSE EFFECTS ASSOCIATED WITH THE PROLONGED USE OF DIHYDROFOLATE REDUCTASE INHIBITORS

摘要

The present invention relates to pharmaceutical compositions containing a combination of reduced forms of folate, liver protectors, vitamins, and essential or non-essential amino acids, useful in preventing the adverse effects associated with prolonged use of dihydrofolate reductase inhibitors.